Patients’ understanding of their disease and engagement in their care and disease are especially important in chronic and complex diseases such as MS. MS patients should be involved in discussions and encouraged to share their considerations, on the basis of which decisions that will affect their life situation for years ahead will be made.

Effective treatments can significantly slow the progression of MS and increase the quality of life of MS patients, but are all associated with side effects of varying severity. It is crucial, therefore, that clinical benefits and their relationship to the probability of side effects are considered, not only by clinicians but also by the patients.¹

One way to engage your patient in their treatment is to make sure you are monitoring what matters to them.